America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Boulder, CO
  4. Apeiron Research Center

Apeiron Research Center

  • Boulder, CO
  • Tax-exempt since 2024
  • EIN: 99-2626938
apeironresearch.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate

Organization summary

Apeiron Research Center is a 501(c)(3) organization, classified under Medical Research (NTEE H92). Contributions are tax-deductible.

1745 38Th Street Suite 100, Boulder, CO 80301-2635

In fiscal year 2025 it reported $4,811,542 in revenue and $1,506,305 in expenses, with contributions making up 99.8% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical research evaluating safety and biologic function. A central program objective is the structured advancement of research findings toward regulatory-compliant autologous Good Manufacturing Practice (GMP) processes that may support future clinical trials and evidence-based therapeutic applications. The organization maintains comprehensive quality management systems to ensure reproducibility, patient protection, and alignment with applicable federal and state regulatory standards. Research results contribute to scientific knowledge.

Main program · fiscal year 2025

  • Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical… Read more

    Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical research evaluating safety and biologic function. A central program objective is the structured advancement of research findings toward regulatory-compliant autologous Good Manufacturing Practice (GMP) processes that may support future clinical trials and evidence-based therapeutic applications. The organization maintains comprehensive quality management systems to ensure reproducibility, patient protection, and alignment with applicable federal and state regulatory standards. Research results contribute to scientific knowledge

    $1,440,854 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 96¢ went to programs, 4¢ to management and 0¢ to fundraising.

  • Programs $1,440,854
  • Management $65,451
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$4,811,542Fiscal year 20252024: $020242025: $4,811,5422025
Expenses$1,506,305Fiscal year 20252024: $020242025: $1,506,3052025
Total assets$4,554,544Fiscal year 20252025: $4,554,5442025
Total liabilities$1,249,307Fiscal year 20252025: $1,249,3072025
Fiscal year ending December 2025
Revenue$4,811,542
Expenses$1,506,305
Net income$3,305,237
Net assets$3,305,237

Notable sources of revenue

Percent of total revenue
Contributions$4,803,605
Program services$0
Investment income$6,447
Other (net)$1,490

Assets / debt

Total assets$4,554,544
Total liabilities$1,249,307
Net assets$3,305,237

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$0
Expenses$0
Net income$0
Net assets$0

Notable sources of revenue

Percent of total revenue
Contributions$0
Program services—
Investment income—
Other (net)$0

Assets / debt

Total assets—
Total liabilities—
Net assets$0

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?